The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain

Cell

Volumn 115, Issue 1, 2003, Pages 83-95

  Elia, Andrew E H ^a,c   Rellos, Peter ^b   Haire, Lesley F ^b   Chao, Jerry W ^a   Ivins, Frank J ^b   Hoepker, Katja ^a   Mohammad, Duaa ^a   Cantley, Lewis C ^c   Smerdon, Stephen J ^b   Yaffe, Michael B ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOPEPTIDE; PHOSPHOSERINE; PHOSPHOTRANSFERASE; POLO LIKE KINASE 1; THREONINE; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BETA CHAIN; CELL CYCLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; LIGAND BINDING; MITOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; STRUCTURE ANALYSIS; X RAY ANALYSIS; XENOPUS; YEAST;

EID: 10744221449     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00725-6     Document Type: Article

References (50)

1. Abrieu A., Brassac T., Galas S., Fisher D., Labbe J.C., Doree M. The Polo-like kinase Plx1 is a component of the MPF amplification loop at the G2/M-phase transition of the cell cycle in Xenopus eggs. J. Cell Sci. 111:1998;1751-1757.
2. Bahassi el M., Conn C.W., Myer D.L., Hennigan R.F., McGowan C.H., Sanchez Y., Stambrook P.J. Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene. 21:2002;6633-6640.
3. Carson M. Ribbons 2.0. J. Appl. Crystallogr. 24:1991;958-961.
4. Conn C.W., Hennigan R.F., Dai W., Sanchez Y., Stambrook P.J. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3. Cancer Res. 60:2000;6826-6831.
5. Descombes P., Nigg E.A. The polo-like kinase Plx1 is required for M phase exit and destruction of mitotic regulators in Xenopus egg extracts. EMBO J. 17:1998;1328-1335.
6. Durocher D., Taylor I.A., Sarbassova D., Haire L.F., Westcott S.L., Jackson S.P., Smerdon S.J., Yaffe M.B. The molecular basis of FHA domain. phosphopeptide binding specificity and implications for phosphodependent signaling mechanisms Mol. Cell. 6:2000;1169-1182.
7. Elez R., Piiper A., Giannini C.D., Brendel M., Zeuzem S. Polo-like kinase1, a new target for antisense tumor therapy. Biochem. Biophys. Res. Commun. 269:2000;352-356.
8. Elia A.E., Cantley L.C., Yaffe M.B. Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science. 299:2003;1228-1231.
9. Glover D.M., Hagan I.M., Tavares A.A. Polo-like kinases. a team that plays throughout mitosis Genes Dev. 12:1998;3777-3787.
10. Golan A., Yudkovsky Y., Hershko A. The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk. J. Biol. Chem. 277:2002;15552-15557.
11. Golsteyn R.M., Schultz S.J., Bartek J., Ziemiecki A., Ried T., Nigg E.A. Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J. Cell Sci. 107:1994;1509-1517.
12. Grallert A., Hagan I.M. Schizosaccharomyces pombe NIMA-related kinase, Fin1, regulates spindle formation and an affinity of Polo for the SPB. EMBO J. 21:2002;3096-3107.
13. Hof P., Pluskey S., Dhe-Paganon S., Eck M.J., Shoelson S.E. Crystal structure of the tyrosine phosphatase SHP-2. Cell. 92:1998;441-450.
14. Izumi T., Maller J.L. Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase. Mol. Biol. Cell. 4:1993;1337-1350.
15. Jang Y.J., Lin C.Y., Ma S., Erikson R.L. Functional studies on the role of the C-terminal domain of mammalian polo-like kinase. Proc. Natl. Acad. Sci. USA. 99:2002;1984-1989.
16. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
17. Kumagai A., Dunphy W.G. Regulation of the cdc25 protein during the cell cycle in Xenopus extracts. Cell. 70:1992;139-151.
18. Lane H.A., Nigg E.A. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J. Cell Biol. 135:1996;1701-1713.
19. Lee K.S., Erikson R.L. Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures. Mol. Cell. Biol. 17:1997;3408-3417.
20. Lee K.S., Yuan Y.L., Kuriyama R., Erikson R.L. Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1. Mol. Cell. Biol. 15:1995;7143-7151.
21. Lee K.S., Grenfell T.Z., Yarm F.R., Erikson R.L. Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc. Natl. Acad. Sci. USA. 95:1998;9301-9306.
22. Lee K.S., Song S., Erikson R.L. The polo-box-dependent induction of ectopic septal structures by a mammalian polo kinase, plk, in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 96:1999;14360-14365.
23. Leung G.C., Hudson J.W., Kozarova A., Davidson A., Dennis J.W., Sicheri F. The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization. Nat. Struct. Biol. 9:2002;719-724.
24. Liu X., Erikson R.L. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc. Natl. Acad. Sci. USA. 100:2003;5789-5794.
25. Liu X., Brodeur S.R., Gish G., Songyang Z., Cantley L.C., Laudano A.P., Pawson T. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Oncogene. 8:1993;1119-1126.
26. Ma S., Liu M.A., Yuan Y.L., Erikson R.L. The serum-inducible protein kinase Snk is a G(1) phase polo-like kinase that is inhibited by the calcium- and integrin-binding protein CIB. Mol. Cancer Res. 1:2003;376-384.
27. May K.M., Reynolds N., Cullen C.F., Yanagida M., Ohkura H. Polo boxes and Cut23 (Apc8) mediate an interaction between polo kinase and the anaphase-promoting complex for fission yeast mitosis. J. Cell Biol. 156:2002;23-28.
28. Moarefi I., LaFevre-Bernt M., Sicheri F., Huse M., Lee C.H., Kuriyan J., Miller W.T. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 385:1997;650-653.
29. Mundt K.E., Golsteyn R.M., Lane H.A., Nigg E.A. On the regulation and function of human polo-like kinase 1 (PLK1). effects of overexpression on cell cycle progression Biochem. Biophys. Res. Commun. 239:1997;377-385.
30. Nicholls A., Sharp K.A., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins. 11:1991;281-296.
31. Nigg E.A. Polo-like kinases. positive regulators of cell division from start to finish Curr. Opin. Cell Biol. 10:1998;776-783.
32. Orlicky S., Tang X., Willems A., Tyers M., Sicheri F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell. 112:2003;243-256.
33. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Meth. Enzymol. 276:1997;307-326.
34. Reynolds N., Ohkura H. Polo boxes form a single functional domain that mediates interactions with multiple proteins in fission yeast polo kinase. J. Cell Sci. 116:2003;1377-1387.
35. Seong Y.S., Kamijo K., Lee J.S., Fernandez E., Kuriyama R., Miki T., Lee K.S. A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cells. J. Biol. Chem. 277:2002;32282-32293.
36. Sicheri F., Moarefi I., Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature. 385:1997;602-609.
37. Smith M.R., Wilson M.L., Hamanaka R., Chase D., Kung H., Longo D.L., Ferris D.K. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem. Biophys. Res. Commun. 234:1997;397-405.
38. Smits V.A., Klompmaker R., Arnaud L., Rijksen G., Nigg E.A., Medema R.H. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat. Cell Biol. 2:2000;672-676.
39. Sonnhammer E.L., Eddy S.R., Birney E., Bateman A., Durbin R. Pfam. multiple sequence alignments and HMM-profiles of protein domains Nucleic Acids Res. 26:1998;320-322.
40. Strausfeld U., Fernandez A., Capony J.P., Girard F., Lautredou N., Derancourt J., Labbe J.C., Lamb N.J. Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis. J. Biol. Chem. 269:1994;5989-6000.
41. Terwilliger T.C., Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55:1999;849-861.
42. Toyoshima-Morimoto F., Taniguchi E., Nishida E. Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep. 3:2002;341-348.
43. Verdecia M.A., Bowman M.E., Lu K.P., Hunter T., Noel J.P. Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat. Struct. Biol. 7:2000;639-643.
44. Xie S., Wu H., Wang Q., Cogswell J.P., Husain I., Conn C., Stambrook P., Jhanwar-Uniyal M., Dai W. Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J. Biol. Chem. 276:2001;43305-43312.
45. Xie S., Wu H., Wang Q., Kunicki J., Thomas R.O., Hollingsworth R.E., Cogswell J., Dai W. Genotoxic stress-induced activation of Plk3 is partly mediated by Chk2. Cell Cycle. 1:2002;424-429.
46. Xu W., Harrison S.C., Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 385:1997;595-602.
47. Yaffe M.B., Cantley L.C. Mapping specificity determinants for protein-protein association using protein fusions and random peptide libraries. Methods Enzymol. 328:2000;157-170.
48. Yaffe M.B., Elia A.E. Phosphoserine/threonine-binding domains. Curr. Opin. Cell Biol. 13:2001;131-138.
49. Yaffe M.B., Smerdon S.J. PhosphoSerine/threonine binding domains. you can't pSERious? Structure. 9:2001;R33-R38.
50. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., Gamblin S.J., Smerdon S.J., Cantley L.C. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell. 91:1997;961-971.